Valuing Prevention Through Economic Evaluation: Some Considerations Regarding the Choice of Discount Model for Health Effects with Focus on Infectious Diseases

Author： Jasper M. Bos   Philippe Beutels   Lieven Annemans   Maarten J. Postma  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.22, Iss.18, 2004-01, pp. : 1171-1179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dynamic Modelling of Infectious Diseases: An Application to the Economic Evaluation of Influenza Vaccination

By Pradas-Velasco Roberto   Antoñanzas-Villar Fernando  

PharmacoEconomics, Vol. 26, Iss. 1, 2008-01 ,pp. : 45-56

Adis International

Access to resources Recommend Favorite

The changing role of economic evaluation in valuing medical technologies

By Rotter Jason S   Foerster Douglas   Bridges John FP  

Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 12, Iss. 6, 2012-12 ,pp. : 711-723

Informa Healthcare

Access to resources Recommend Favorite

Health economic considerations in the treatment of schizophrenia

By Souetre E.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 165-165

Elsevier

Access to resources Recommend Favorite

Combating Infectious Diseases through Multivalent Design

By  

Current Drug Targets - Infectious Disorders, Vol. 2, Iss. 2, 2002-06 ,pp. : 161-167

Bentham Science Publishers

Access to resources Recommend Favorite

Choice of Cost-Effectiveness Measure in the Economic Evaluation of Cholesterol-Modifying Pharmacotherapy: An Illustrative Example Focusing on the Primary Prevention of Coronary Heart Disease in Canada

By Morris S.  

PharmacoEconomics, Vol. 16, Iss. 2, 1999-08 ,pp. : 193-205

Adis International

Access to resources Recommend Favorite